Inactive Instrument
Calliditas Therapeutics AB Stock
Stocks
0A5R
SE0010441584
Pharmaceuticals
OTC Markets Traded| 1 day | +0.98% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 49 | 2017-07-31 | |
Lars Stubberud
CTO | Chief Tech/Sci/R&D Officer | 62 | 2023-12-31 |
| Chief Tech/Sci/R&D Officer | - | 2019-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Hensley
CHM | Chairman | 43 | - |
Yoshikazu Aoki
BRD | Director/Board Member | - | - |
Masaya Etoh
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/4/24 | Sell | Chairman | 56,860 | 0.0954% | ||
| 9/4/24 | Sell | Chief Financial Officer | 10,000 | 0.0168% | ||
| 9/4/24 | Sell | 13,535 | 0.0227% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.98% | -0.19% | - | - | 1.16B | ||
| -0.30% | -6.68% | +29.12% | +125.42% | 1,204B | ||
| +1.25% | -5.35% | +33.19% | +80.42% | 643B | ||
| +0.94% | -2.99% | +24.73% | +106.93% | 501B | ||
| -0.60% | -1.95% | +27.26% | +67.32% | 378B | ||
| +0.69% | -9.50% | +40.80% | +30.23% | 327B | ||
| +0.41% | -4.70% | +27.23% | +51.59% | 285B | ||
| +0.81% | -4.08% | -1.74% | +32.71% | 270B | ||
| -0.15% | -6.45% | +29.63% | +64.18% | 237B | ||
| -0.06% | -0.98% | +33.15% | +118.99% | 207B | ||
| Average | +0.43% | -4.79% | +27.04% | +75.31% | 450B | |
| Weighted average by Cap. | +0.39% | -5.21% | +28.04% | +87.59% |
Employees
222
Sector
Pharmaceuticals
















